About Camus Pharma
Camus Pharma is a company based in Jaipur (India) founded in 1997. It operates as a B2B. Camus Pharma offers products and services including Formulations and Active Pharmaceutical Ingredients. Camus Pharma operates in a competitive market with competitors including Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
- Headquarter Jaipur, India
- SectorsHealthcare
- Email••••••••
- Website camuspharma.com
- Legal Name Camus Pharma Private Limited
- Date of Incorporation 01 Jul, 1997
- Jurisdiction Jaipur, Rajasthan, India
- Annual Revenue₹122 Cr
FY 2025 · +68% YoY
- Net Profit₹3.98 Cr
FY 2025 · 3% margin
- EBITDA₹7.34 Cr
FY 2025 · 6% margin
Associated legal entities of Camus Pharma
Camus Pharma operates through Camus Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Camus Pharma Private Limited CIN U24232RJ1997PTC013970 | Active | 01 Jul 1997 | Jaipur, Rajasthan | ₹122 Cr | – | 2 | View details |
Products & Services of Camus Pharma
Camus Pharma offers a comprehensive portfolio of products and services, including Formulations and Active Pharmaceutical Ingredients.
Manufactured drug formulations for treating conditions like asthma
Essential components for producing pharmaceutical drugs
Board of directors of Camus Pharma Private Limited (Camus Pharma)
Camus Pharma Private Limited is the primary company behind Camus Pharma. The board of Camus Pharma Private Limited currently have 2 directors; the longest-serving is Suresh Chandra Dhabash, appointed in 2018. 9 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Suresh Chandra Dhabash DIN 08229355 | Director | 20 Sep 2018 | 8 yrs | Camus Pharma Private Limited |
| Dinesh Kumar DIN 08229345 | Director | 20 Sep 2018 | 8 yrs | Camus Pharma Private Limited |
Financials of Camus Pharma
Figures of Camus Pharma Private Limited, the primary company behind Camus Pharma, for FY 2025. Revenue was ₹122 Cr (+68% year on year). Net profit was ₹3.98 Cr (3% margin). EBITDA was ₹7.34 Cr (6% margin). Revenue has grown at a compounded annual rate of +37% over three years and -5% over five years.
- ₹122 CrRevenue · FY 2025 · +68% YoY
- ₹3.98 CrNet profit · 3% margin
- ₹7.34 CrEBITDA · 6% margin
- ₹25 LakhPaid-up capital
- +37%Revenue CAGR, 3 years
- -5%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Camus Pharma Private Limited are on its company page.
Detailed financial statements for Camus Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Camus Pharma
Camus Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| provepharm.com | 1998 | Marseille, France | $145.93M | – | APIs and drug products are developed and valorized in pharmaceuticals. | |
| biostar-pharm.com | 2002 | Beijing, China | $135.23M | – | APIs, intermediates, and biochemical reagents are developed and manufactured. | |
| sequent.in | 2002 | Bengaluru, India | – | – | APIs are developed and manufactured for therapeutic areas. | |
| sterlingpharmasolutions.com | 2016 | Dudley, United Kingdom | – | 560 | Contract development, manufacturing, and analytical services for APIs are offered. | |
| snapdragonchemistry.com | 2014 | Cambridge, United States | – | 43 | Drug discovery and development service provider | |
| jubilantpharma.com | 1978 | Noida, India | – | – | Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. | |
| hikal.com | 1988 | Mumbai, India | – | 355 | APIs and intermediates are produced via custom synthesis and research. |
Detailed competitors of Camus Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Camus Pharma
10 companies that operate in the same segment as Camus Pharma (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Camus Pharma
Camus Pharma was founded in 1997.
Camus Pharma is headquartered in Jaipur, India. It is registered at Jaipur, Rajasthan, India.
The primary company behind Camus Pharma, Camus Pharma Private Limited, reported revenue of ₹122 Cr for FY 2025, up 68% year on year.
Camus Pharma, established in 1997, began as a trading company and evolved into a full manufacturing entity with bases at six locations in India. It produces and trades innovative pharmaceutical products in segments like asthma, COPD, tuberculosis, ARV, oncology, antibiotics, and biotech. The company operates in India, Russia, CIS, and China, with plans for regulated market expansion, serving business clients through trading and production activities.
Camus Pharma's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.
Camus Pharma offers Formulations and Active Pharmaceutical Ingredients.
Camus Pharma operates through Camus Pharma Private Limited.
The legal entities of Camus Pharma currently have 2 directors, including Suresh Chandra Dhabash, Dinesh Kumar.